The Let MI Doctors Decide initiative has released a new report card on the 25 largest health plans within Michigan’s Medicare prescription drug program. It examines the use of access restrictions, such as step therapy and prior authorization, on seniors with autoimmune diseases.
The new resource is particularly timely given the proposed rule issued by the Centers for Medicare and Medicaid Services (CMS) earlier this week that would broaden the use of step therapy within the Medicare program.
Let MI Doctors Decide is led by the Michigan-based American Autoimmune Related Diseases Association (AARDA) in partnership with five local patient advocacy and health care organizations. The initiative aims to help patients and doctors navigate step therapy practices. To learn more, visit letmidoctorsdecide.org.